Together we can accomplish great things! It’s always amazing to watch how individuals coming together as one united voice can truly make a difference in the lives of others.

On May 1^st and 2^nd I had the pleasure of representing CBCN at an Advisory Committee meeting for the Inuit Cancer Project lead by Pauktuutit Inuit Women of Canada in Iqaluit, NU. This meeting gave those involved in the project an opportunity to meet face to face to discuss an overview of the project, how it was proceeding, along with an update of recent activities and roundtable discussions. These roundtable discussions included opportunities to speak about lessons learned, ways to build community engagement, community capacity and next steps.

It’s powerful what happens when patients, caregivers, and clinicians come together to look at research priorities; a broad list of questions that encompasses a variety of viewpoints emerges.

There’s been a lot of talk lately about new metastatic breast cancer treatments that can greatly extend the lives of many people in Canada. Targeted therapies are changing the landscape for mBC in a big way.

February 4^th marks World Cancer Day, a global event that takes place every year uniting people around the world who are concerned about the fight against cancer. Currently, 8.8 million people die from cancer globally every year and breast cancer is the most commonly diagnosed cancer in women.

This year I was honoured to participate as a patient representative on the steering committee of the Canadian Cancer Research Conference hosted by the Canadian Cancer Research Alliance at the beginning of November. 

This holiday season consider adding CBCN to your list for charitable giving! Here’s what you’ll be supporting.

CBCN is excited to announce that we’ve been awarded an international SPARC grant, Seeding Progress and Resources for the Cancer Community: Metastatic Breast Cancer Challenge, to develop a mBC Financial Resources Navigation Tool.

Increasingly the not-for-profit advocacy world has been clouded with criticism of industry funding. Many critics believe that any organization that receives funding from the pharmaceutical industry is automatically biased, but this ignores the great pains that health charities often go through to remain unbiased, ethical and credible. And it certainly does not reflect the patient-centric approach that CBCN takes.

How valuable is patient input to decision-makers and how can we work to make sure that the patient voice is really being heard? These are just some of the important questions that I and many others gathered to discuss at the annual Breast Cancer Patient Group Forum in Vienna, Austria.